Silicon Valley Bank led a $55 million senior secured term loan for US HealthVest, a developer and operator of behavioral health facilities. The financing included a $30 million first lien revolving line and term loan from SVB and a $25 million second lien term loan from a third party.
SVB, MidCap Financial Provide $100MM Facility to Organogenesis
March 15, 2019
SVB and MidCap Financial entered a $100 million credit agreement with Organogenesis, a regenerative medicine company focused on product solutions for the advanced wound care and surgical and sports medicine markets.
OnDeck Receives $85MM Revolver Arranged by SunTrust, SVB
February 7, 2019
Small business online lender OnDeck closed an $85 million corporate revolving credit facility. SunTrust Bank and Silicon Valley Bank served as arrangers on the facility, while MB Financial Bank and Congressional Bank joined them as lenders.
App Developer Fair Closes $50MM Debt Facility with SVB
January 28, 2019
Car app company Fair closed a $50 million debt facility with Silicon Valley Bank. The funds will be used to buy cars for the company’s users as it begins to scale globally.
JPMorgan Chase, BofAML Arrange $145MM Facility for Jam City
January 17, 2019
JPMorgan Chase Bank acted as sole bookrunner and, alongside Bank of America Merrill Lynch, joint lead arranger on $145 million in strategic financing for mobile game developer Jam City.
SVB Names Cox to COO, Platts to EMEA Head/UK Branch President
January 14, 2019
Silicon Valley Bank appointed Phil Cox its new chief operations officer. Erin Platts will take over as head of EMEA and president of the UK Branch from Cox. Both will take on their new duties on April 1, 2019.
SVB Acquires Healthcare Investment Bank Leerink Partners
January 7, 2019
SVB Financial Group, parent company of Silicon Valley Bank, completed its acquisition of Boston-based healthcare and life science investment bank Leerink Partners.
SVB, MidCap Financial Provide $25MM Term Loan to Ocular Therapeutix
January 2, 2019
MidCap Financial and Silicon Valley Bank provided a new $25 million term loan to Ocular Therapeutix, a biopharmaceutical company focused on the development of therapies for diseases and conditions of the eye.
Regions Agents $100MM Expansion of Ebix Credit Facility
November 30, 2018
Ebix expanded its existing syndicated credit facility by an additional $100 million. Regions Bank led the banking group and served as both administrative and collateral agent on the transaction.
